Patel, Preeya J.
Weidenfeller, Christian
Jones, Andrew P.
Nilsson, Jens
Hsu, Jay
Clinical trials referenced in this document:
Documents that mention this clinical trial
Long-Term Assessment of Lurasidone in Schizophrenia: Post Hoc Analysis of a 12-Month, Double Blind, Active-Controlled Trial and 6-Month Open-Label Extension Study
https://doi.org/10.1007/s40120-020-00221-4
Funding for this research was provided by:
Sunovion Pharmaceuticals Europe Ltd
Article History
Received: 17 September 2020
Accepted: 14 October 2020
First Online: 24 October 2020